Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series.

@article{Shih2010TertiaryCI,
  title={Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series.},
  author={Karin K. Shih and Dennis Chi and Richard R. Barakat and Mario M M Leitao},
  journal={Gynecologic oncology},
  year={2010},
  volume={117 2},
  pages={330-5}
}
OBJECTIVE Surgical cytoreduction is an integral therapeutic modality for patients with epithelial ovarian (EOC), fallopian tube (FTC), or primary peritoneal (PPC) cancer in the primary setting. The role of surgical cytoreduction in the recurrent setting is not clearly defined and remains controversial. The objective of this study was to assess this potential survival benefit in a large cohort of patients with a long follow-up period. METHODS We performed a retrospective chart review of all… CONTINUE READING
19 Citations
26 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

The role of secondary cytoreductive surgery for recurrent ovarian cancer

  • GungorM, F Ortaç, M Arvas, D Kösebay, M Sönmezer, K. Köse
  • Gynecol Oncol 2005;97:74–9
  • 2005

Similar Papers

Loading similar papers…